Pharmacogenomic-guided dosing for warfarin: too little too late?

Per Med. 2018 Mar;15(2):71-73. doi: 10.2217/pme-2017-0080. Epub 2018 Jan 29.
No abstract available

Keywords: dosing; economic analysis; novel oral anticoagulants; pharmacogenomics; quality adjusted life years; randomized clinical trials; warfarin.

Publication types

  • Editorial

MeSH terms

  • Anticoagulants / administration & dosage
  • Dose-Response Relationship, Drug
  • Humans
  • Pharmacogenetics / methods
  • Warfarin / administration & dosage*
  • Warfarin / economics*
  • Warfarin / pharmacology*

Substances

  • Anticoagulants
  • Warfarin